CHARLES WISNIEWSKI: Open Payments
NPI 1770997587 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 16 payments from 6 companies in 2025. Trend: 2023 $19 · 2024 $0 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $138 |
| Exact Sciences Corporation | 4 | $103 |
| ABBVIE INC. | 3 | $95 |
| Novo Nordisk Inc | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: INGREZZA, MAVYRET, The Cologuard Plus Collection Kit, Cologuard Collection Kit, VRAYLAR, Wegovy, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
